Farringdon Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$320K Buy
+7,331
New +$339K 0.2% 146
2026
Q2
– Sell
-38,104
Closed -$2.39M – 226
2026
Q1
$2.39M Buy
+38,104
New +$3.05M 0.52% 52
2025
Q4
– Sell
-22,570
Closed -$2.2M – 460
2025
Q3
$2.2M Buy
+22,570
New +$2.34M 0.56% 31
2025
Q2
– Sell
-2,086
Closed -$210K – 445
2025
Q1
$210K Buy
+2,086
New +$210K 0.11% 280

Other funds holding BSX

Farringdon Capital's BSX Position: Q3 2026 in Review

Farringdon Capital opened a new position in Boston Scientific (BSX) in Q3 2026: 7,331 shares worth $320K. The stake represents 0.2% of the portfolio and ranks #146 among its holdings. This is a return to the name: Farringdon Capital previously reported a position in BSX as recently as Q1 2026.

Farringdon Capital first reported a position in BSX in Q1 2025 and has held it in 4 quarters since. The position peaked at $2.39M in Q1 2026. 1,492 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Farringdon Capital held 7,331 shares of Boston Scientific worth $320K as of Q3 2026.
  • Boston Scientific was a new Farringdon Capital position in Q3 2026.
  • Boston Scientific made up 0.2% of Farringdon Capital's portfolio in Q3 2026, its #146 holding.
  • Farringdon Capital first reported a position in Boston Scientific in Q1 2025 and has held it in 4 quarters since.
  • Farringdon Capital's Boston Scientific position peaked at $2.39M in Q1 2026.
  • 1,492 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Farringdon Capital's 13F filing for Q3 2026, filed 16 Nov 2026.